<DOC>
	<DOCNO>NCT00003115</DOCNO>
	<brief_summary>RATIONALE : Giving hydromorphone different way may relieve pain associated cancer surgery . PURPOSE : Randomized double-blinded phase III trial compare effectiveness epidural hydromorphone hydromorphone infusion patient prostate cancer undergo radical prostatectomy .</brief_summary>
	<brief_title>Epidural Hydromorphone Compared With Hydromorphone Infusion Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy</brief_title>
	<detailed_description>OBJECTIVES : I . Define duration action hydromorphone ( spinal v supraspinal ) patient undergone radical prostatectomy . II . Demonstrate duration analgesic effect equal blood concentration hydromorphone dependent method use attain concentration compare continuous epidural infusion continuous intravenous infusion . OUTLINE : This double blind , randomize study . After patient undergone radical prostatectomy , hydromorphone administer two different way . Patients receive either hydromorphone bolus injection epidural catheter use patient control analgesia pump hydromorphone bolus injection intravenous catheter use patient control analgesia pump . Infusion group stop 24 hour . Patients follow every 30 minute 6 hour . PROJECTED ACCRUAL : A total 40 patient accrue study 3 year period .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm prostate cancer Not metastatic Must undergo radical prostatectomy PATIENT CHARACTERISTICS : Age : 1870 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Neurologic : No presence intracranial lesion associate increase intracranial pressure Pulmonary : No chronic obstructive pulmonary disease No cor pulmonale No emphysema No kyphoscoliosis No status asthmaticus Other : No contraindication insertion epidural catheter No known hypersensitivity hydromorphone No history alcoholism , drug abuse , mental dysfunction , cognitive deficiency PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify prior surgery ( y ) Other : No preoperative opioids reason</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>pain</keyword>
</DOC>